- Selective laser trabeculoplasty (SLT) reduced medication use and provided additional intraocular pressure control for open-angle glaucoma and ocular hypertension.
- SLT may offer a cost-effective approach for glaucoma treatment.
- Study researchers reported a significant reduction in medication burden for participants switching to SLT after 3 years of eye drop use.
- In stable eyes, SLT showed potential for eye drop–free intraocular pressure control for at least 3 years.
- SLT may not fully prevent the need for definitive surgical pressure lowering in advanced glaucoma cases.
Source: JAMA Ophthalmology
